Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents. [electronic resource]
Producer: 20160524Description: e0137833 p. digitalISSN:- 1932-6203
- Adult
- Aged
- Aged, 80 and over
- Ambulatory Care Facilities
- Angiogenesis Inhibitors -- administration & dosage
- Bevacizumab -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Intraocular Pressure -- drug effects
- Intravitreal Injections
- Macular Edema -- complications
- Male
- Middle Aged
- Patient Outcome Assessment
- Prospective Studies
- Ranibizumab -- administration & dosage
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.